313 related articles for article (PubMed ID: 30081037)
41. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
42. Apolipoprotein E in Alzheimer's disease: an update.
Yu JT; Tan L; Hardy J
Annu Rev Neurosci; 2014; 37():79-100. PubMed ID: 24821312
[TBL] [Abstract][Full Text] [Related]
43. Regionally specific neuronal expression of human APOE gene in transgenic mice.
Xu PT; Gilbert JR; Qiu HL; Rothrock-Christian T; Settles DL; Roses AD; Schmechel DE
Neurosci Lett; 1998 Apr; 246(2):65-8. PubMed ID: 9627181
[TBL] [Abstract][Full Text] [Related]
44. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
45. Microglial activation induced by factor(s) contained in sera from Alzheimer-related ApoE genotypes.
Lombardi VR; García M; Cacabelos R
J Neurosci Res; 1998 Nov; 54(4):539-53. PubMed ID: 9822164
[TBL] [Abstract][Full Text] [Related]
46. Lack of allelic imbalance in APOE epsilon3/4 brain mRNA expression in Alzheimer's disease.
Growdon WB; Cheung BS; Hyman BT; Rebeck GW
Neurosci Lett; 1999 Sep; 272(2):83-6. PubMed ID: 10507547
[TBL] [Abstract][Full Text] [Related]
47. Alzheimer's disease: the cholesterol connection.
Puglielli L; Tanzi RE; Kovacs DM
Nat Neurosci; 2003 Apr; 6(4):345-51. PubMed ID: 12658281
[TBL] [Abstract][Full Text] [Related]
48. APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism.
Kamboh MI; Sanghera DK; Ferrell RE; DeKosky ST
Nat Genet; 1995 Aug; 10(4):486-8. PubMed ID: 7670501
[TBL] [Abstract][Full Text] [Related]
49. Elevated DRD4 promoter methylation increases the risk of Alzheimer's disease in males.
Ji H; Wang Y; Jiang D; Liu G; Xu X; Dai D; Zhou X; Cui W; Li J; Chen Z; Li Y; Zhou D; Zha Q; Zhuo R; Jiang L; Liu Y; Shen L; Zhang B; Xu L; Hu H; Zhang Y; Yin H; Duan S; Wang Q
Mol Med Rep; 2016 Sep; 14(3):2732-8. PubMed ID: 27485706
[TBL] [Abstract][Full Text] [Related]
50. Epigenetic modifications in frontal cortex from Alzheimer's disease and bipolar disorder patients.
Rao JS; Keleshian VL; Klein S; Rapoport SI
Transl Psychiatry; 2012 Jul; 2(7):e132. PubMed ID: 22760556
[TBL] [Abstract][Full Text] [Related]
51. Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients.
Ji Y; Gong Y; Gan W; Beach T; Holtzman DM; Wisniewski T
Neuroscience; 2003; 122(2):305-15. PubMed ID: 14614898
[TBL] [Abstract][Full Text] [Related]
52. Association between apolipoprotein E e4 allele and arteriosclerosis, cerebral amyloid angiopathy, and cerebral white matter damage in Alzheimer's disease.
Tian J; Shi J; Bailey K; Lendon CL; Pickering-Brown SM; Mann DM
J Neurol Neurosurg Psychiatry; 2004 May; 75(5):696-9. PubMed ID: 15090562
[TBL] [Abstract][Full Text] [Related]
53. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
54. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease.
Itzhaki RF; Lin WR; Shang D; Wilcock GK; Faragher B; Jamieson GA
Lancet; 1997 Jan; 349(9047):241-4. PubMed ID: 9014911
[TBL] [Abstract][Full Text] [Related]
55. CpG and non-CpG Presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain.
Monti N; Cavallaro RA; Stoccoro A; Nicolia V; Scarpa S; Kovacs GG; Fiorenza MT; Lucarelli M; Aronica E; Ferrer I; Coppedè F; Troen AM; Fuso A
Epigenetics; 2020 Aug; 15(8):781-799. PubMed ID: 32019393
[TBL] [Abstract][Full Text] [Related]
56. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population.
Zurutuza L; Verpillat P; Raux G; Hannequin D; Puel M; Belliard S; Michon A; Pothin Y; Camuzat A; Penet C; Martin C; Brice A; Campion D; Clerget-Darpoux F; Frebourg T
Eur J Hum Genet; 2000 Sep; 8(9):713-6. PubMed ID: 10980578
[TBL] [Abstract][Full Text] [Related]
57. The -491AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease.
Laws SM; Taddei K; Martins G; Paton A; Fisher C; Clarnette R; Hallmayer J; Brooks WS; Gandy SE; Martins RN
Neuroreport; 1999 Mar; 10(4):879-82. PubMed ID: 10208564
[TBL] [Abstract][Full Text] [Related]
58. Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brain.
Ramassamy C; Averill D; Beffert U; Theroux L; Lussier-Cacan S; Cohn JS; Christen Y; Schoofs A; Davignon J; Poirier J
Neurobiol Dis; 2000 Feb; 7(1):23-37. PubMed ID: 10671320
[TBL] [Abstract][Full Text] [Related]
59. APOE genetic variants and apoE, miR-107 and miR-650 levels in Alzheimer's disease.
Prendecki M; Florczak-Wyspianska J; Kowalska M; Ilkowski J; Grzelak T; Bialas K; Kozubski W; Dorszewska J
Folia Neuropathol; 2019; 57(2):106-116. PubMed ID: 31556571
[TBL] [Abstract][Full Text] [Related]
60. Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controls.
Pirttilä T; Soininen H; Heinonen O; Lehtimäki T; Bogdanovic N; Paljärvi L; Kosunen O; Winblad B; Riekkinen P; Wisniewski HM; Mehta PD
Brain Res; 1996 May; 722(1-2):71-7. PubMed ID: 8813351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
